AP3342A - Imidazole derivatives as PDE10A enzyme inhibitors - Google Patents

Imidazole derivatives as PDE10A enzyme inhibitors

Info

Publication number
AP3342A
AP3342A AP2013006928A AP2013006928A AP3342A AP 3342 A AP3342 A AP 3342A AP 2013006928 A AP2013006928 A AP 2013006928A AP 2013006928 A AP2013006928 A AP 2013006928A AP 3342 A AP3342 A AP 3342A
Authority
AP
ARIPO
Prior art keywords
enzyme inhibitors
imidazole derivatives
pde10a enzyme
pde10a
imidazole
Prior art date
Application number
AP2013006928A
Other languages
English (en)
Other versions
AP2013006928A0 (en
Inventor
Jacob Nielsen
Jan Kehler
Mauro Marigo
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AP2013006928A0 publication Critical patent/AP2013006928A0/xx
Application granted granted Critical
Publication of AP3342A publication Critical patent/AP3342A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AP2013006928A 2010-11-19 2011-11-18 Imidazole derivatives as PDE10A enzyme inhibitors AP3342A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201001045 2010-11-19
PCT/DK2011/000136 WO2012065612A1 (fr) 2010-11-19 2011-11-18 Dérivé d'imidazole en tant qu'inhibiteurs de l'enzyme pde10a

Publications (2)

Publication Number Publication Date
AP2013006928A0 AP2013006928A0 (en) 2013-06-30
AP3342A true AP3342A (en) 2015-07-31

Family

ID=45217102

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2013006928A AP3342A (en) 2010-11-19 2011-11-18 Imidazole derivatives as PDE10A enzyme inhibitors

Country Status (32)

Country Link
EP (1) EP2640731B9 (fr)
JP (1) JP5937608B2 (fr)
KR (1) KR101916487B1 (fr)
CN (1) CN103328487B (fr)
AP (1) AP3342A (fr)
AR (1) AR083926A1 (fr)
AU (1) AU2011331607B2 (fr)
BR (1) BR112013012378A2 (fr)
CA (1) CA2817663C (fr)
CR (1) CR20130226A (fr)
DK (1) DK2640731T3 (fr)
EA (1) EA027082B1 (fr)
EC (1) ECSP13012698A (fr)
ES (1) ES2547090T3 (fr)
GE (1) GEP20156346B (fr)
GT (1) GT201300130A (fr)
HU (1) HUE025596T2 (fr)
JO (1) JO3089B1 (fr)
ME (1) ME02193B (fr)
MY (1) MY163327A (fr)
NZ (1) NZ610353A (fr)
PE (1) PE20141534A1 (fr)
PH (1) PH12013500968A1 (fr)
PL (1) PL2640731T3 (fr)
PT (1) PT2640731E (fr)
RS (1) RS54210B1 (fr)
SG (1) SG190282A1 (fr)
SI (1) SI2640731T1 (fr)
TW (1) TWI541245B (fr)
UA (1) UA112065C2 (fr)
WO (1) WO2012065612A1 (fr)
ZA (1) ZA201303607B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8552045B2 (en) 2010-11-19 2013-10-08 H. Lundbeck A/S Tricyclic imidazole compounds as PDE10 inhibitors
WO2012096929A2 (fr) * 2011-01-11 2012-07-19 Sunovion Pharmaceuticals Inc. Composés hétéroaryles et leurs procédés d'utilisation
WO2013045607A1 (fr) * 2011-09-30 2013-04-04 H. Lundbeck A/S Dérivés tricycliques hétéroaromatiques liés à de la quinazoline pouvant être utilisés en tant qu'inhibiteurs de l'enzyme pde10a
WO2013107856A1 (fr) * 2012-01-20 2013-07-25 H. Lundbeck A/S Dérivés d'imidazole utilisés comme inhibiteurs d'enzymes pde10a
US9505751B2 (en) 2012-06-19 2016-11-29 Sunovion Pharmaceuticals Inc. Substituted [1,2,4]triazolo[1,5-a]pyrazines as phosphodiesterase inhibitors
CN103435617B (zh) * 2013-08-22 2016-04-27 南京华安药业有限公司 一种6,7-二氢-5H-吡咯并[1,2-a]咪唑-2-甲醛的合成方法
JO3627B1 (ar) 2015-04-30 2020-08-27 H Lundbeck As إيميدازو بيرازينونات على هيئة مثبطات pde1
TWI729109B (zh) 2016-04-12 2021-06-01 丹麥商H 朗德貝克公司 作爲PDE1抑制劑的1,5-二氫-4H-吡唑并[3,4-d]嘧啶-4-酮和1,5-二氫-4H-吡唑并[4,3-c]吡啶-4-酮
ES2967489T3 (es) 2016-10-18 2024-04-30 H Lundbeck As Imidazopirazinonas, pirazolopirimidinonas y pirazolopiridinonas como inhibidores de PDE1
MA46621A (fr) 2016-10-28 2021-06-02 H Lundbeck As Traitements combinés comprenant l'administration d'imidazopyrazinones
EP3532064B1 (fr) 2016-10-28 2020-07-29 H. Lundbeck A/S Traitements combinés comprenant des imidazopyrazinones pour le traitement de troubles psychiatriques et/ou cognitifs
TW202031250A (zh) 2018-11-06 2020-09-01 丹麥商H 朗德貝克公司 用於治療負性症狀和認知損傷之pde10a抑制劑
CN109776527A (zh) * 2019-02-21 2019-05-21 药雅科技(上海)有限公司 一种5-溴-7-氮杂吲哚的合成方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009152825A1 (fr) * 2008-06-20 2009-12-23 H. Lundbeck A/S Nouveau dérivés de phénylimidazole convenant comme inhibiteurs de l'enzyme pde10a

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307865D0 (en) 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
US5571775A (en) 1994-07-11 1996-11-05 Dowelanco N-aryl[1,2,4]triazolo[1,5-a]pyridine-2-sulfonamide herbicides
US20030032579A1 (en) 2001-04-20 2003-02-13 Pfizer Inc. Therapeutic use of selective PDE10 inhibitors
IL149106A0 (en) 2001-04-20 2002-11-10 Pfizer Prod Inc Therapeutic use of selective pde10 inhibitors
WO2005003129A1 (fr) 2003-06-30 2005-01-13 Altana Pharma Ag Pyrrolodihydroisoquinolines comme inhibiteurs de pde10
WO2005002579A1 (fr) 2003-06-30 2005-01-13 Altana Pharma Ag Derives de pyrrolo-dihydroisoquinoline comme inhibiteurs de pde10
EP1651251A4 (fr) 2003-07-31 2008-06-18 Bayer Pharmaceuticals Corp Procedes pour traiter le diabete, et les troubles associes, au moyen d'inhibiteurs des pde10a
EP1723134A2 (fr) 2004-02-18 2006-11-22 Pfizer Products Incorporated Derives tetrahydroisoquinolinyliques de quinazoline et d'isoquinoline
MXPA06014236A (es) 2004-06-07 2007-02-14 Pfizer Prod Inc Inhibicion de la fosfodiesterasa 10 como tratamiento para las afecciones relacionadas con el sindrome metabolico y con la obesidad.
US20060019975A1 (en) 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
CA2578996A1 (fr) 2004-09-03 2006-03-16 Memory Pharmaceuticals Corporation Derives de 4, 6-dialkoxy-cinnoline substitues en position 4 en tant qu'inhibiteurs de phospodiesterase 10 pour le traitement de syndromes psychiatriques ou neurologiques
US8133897B2 (en) 2008-06-20 2012-03-13 H. Lundbeck A/S Phenylimidazole derivatives as PDE10A enzyme inhibitors
UA102693C2 (ru) * 2008-06-20 2013-08-12 Х. Луннбек А/С Производные фенилимидазола как ингибиторы фермента pde10a
TW201200516A (en) * 2009-12-17 2012-01-01 Lundbeck & Co As H Phenylimidazole derivatives comprising an ethynylene linker as PDE10A enzyme inhibitors
TWI481607B (zh) * 2009-12-17 2015-04-21 Lundbeck & Co As H 作為pde10a酵素抑制劑的2-芳基咪唑衍生物
TWI485151B (zh) * 2009-12-17 2015-05-21 Lundbeck & Co As H 作為pde10a酵素抑制劑之雜芳香族苯基咪唑衍生物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009152825A1 (fr) * 2008-06-20 2009-12-23 H. Lundbeck A/S Nouveau dérivés de phénylimidazole convenant comme inhibiteurs de l'enzyme pde10a

Also Published As

Publication number Publication date
PL2640731T3 (pl) 2015-11-30
GT201300130A (es) 2015-01-16
CN103328487A (zh) 2013-09-25
ES2547090T3 (es) 2015-10-01
ME02193B (me) 2016-02-20
ECSP13012698A (es) 2013-08-30
AU2011331607A1 (en) 2013-05-30
PH12013500968A1 (en) 2022-10-24
AP2013006928A0 (en) 2013-06-30
EP2640731B9 (fr) 2015-11-25
JO3089B1 (ar) 2017-03-15
AR083926A1 (es) 2013-04-10
CA2817663C (fr) 2020-04-28
KR101916487B1 (ko) 2018-11-07
JP2013542963A (ja) 2013-11-28
TW201300391A (zh) 2013-01-01
CN103328487B (zh) 2015-11-25
TWI541245B (zh) 2016-07-11
EA027082B1 (ru) 2017-06-30
UA112065C2 (uk) 2016-07-25
CR20130226A (es) 2013-09-03
GEP20156346B (en) 2015-08-10
JP5937608B2 (ja) 2016-06-22
AU2011331607B2 (en) 2016-05-19
EP2640731B1 (fr) 2015-07-08
MY163327A (en) 2017-09-15
PT2640731E (pt) 2015-10-13
EA201390741A1 (ru) 2013-11-29
HUE025596T2 (en) 2016-03-29
EP2640731A1 (fr) 2013-09-25
WO2012065612A1 (fr) 2012-05-24
RS54210B1 (sr) 2015-12-31
ZA201303607B (en) 2014-07-30
SG190282A1 (en) 2013-06-28
DK2640731T3 (en) 2015-08-31
BR112013012378A2 (pt) 2016-08-30
PE20141534A1 (es) 2014-11-16
NZ610353A (en) 2015-01-30
SI2640731T1 (sl) 2015-10-30
CA2817663A1 (fr) 2012-05-24
KR20140009192A (ko) 2014-01-22

Similar Documents

Publication Publication Date Title
AP3342A (en) Imidazole derivatives as PDE10A enzyme inhibitors
IL209834A (en) Phenylimidazole derivatives as a10pde enzyme sequences
IL253102A0 (en) History of hydantoins used as kv3 inhibitors
IL221823A (en) Pipridine-4-Il-Aztidine Derivatives as Jack 1 Suppressors
ZA201204418B (en) 2-arylimidazole derivatives as pde10a enzyme inhibitors
GB201004179D0 (en) Enzyme inhibitors
ZA201204419B (en) Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors
GB201004178D0 (en) Enzyme inhibitors
ZA201204420B (en) Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors
IL216684A0 (en) Novel phenylimidazole derivative as pde10a enzyme inhibitor
PT2721009E (pt) Derivados de pirazole úteis como inibidores de aldosterona sintase
ZA201404533B (en) Quinoline derivatives as pde10a enzyme inhibitors
IL226344A0 (en) Imiazole derivatives as enzyme inhibitors@pde
GB201004309D0 (en) New enzyme inhibitors